Gou et al. [15] reported that the administration of IL-7 combined with oxaliplatin effectively inhibited the growth of tumors in lung and abdomen metastasis models of colon cancer, which was associated with up-regulation of tumor-infiltrating activated CD8+ T cells and down-regulation of regulatory T (Treg) cells in spleen. The gene discussed is CD8A; the disease is neoplasm.